Interprofessional Issues Novel, Interprofessional Approach Enhances Bed Assignments for Individuals on Antineoplastic Drugs in a Hospital Setting August 22, 2024
Nurse Empowerment Sharing Our Stories Supports, Celebrates, and Advances the Nursing Profession July 04, 2024
Nurse Well-Being When Health Care Is Woven in Our Family Fabric, We Find Support in Unexpected Places March 07, 2024
Trending Topics Research Safety Nurse Well-Being Drug Reference Sheets ONS Congress Specific Populations View All Topics
U.S. Food and Drug Administration (FDA) FDA Approves First Biosimilar to Pegfilgrastim to Decrease Cancer Treatment Infection Risk June 05, 2018
Radiation Therapy How Do Nurse Practitioners Support Patients With Cancer During Radiation? June 05, 2018
Breast Cancer Which Breast Cancers Benefit from Treatment With Cyclin-Dependent Kinase 4/6 Inhibitor Treatment? May 31, 2018
Evidence-Based Practice Overcome Barriers to Applying an Evidence-Based Process for Practice Change May 30, 2018
Immunotherapy Here’s an Overview of the Types, Mechanisms, and Side Effects of Currently Approved Immunotherapies May 29, 2018
Genetics & Genomics BRCA Mutations Point to Hereditary Breast and Ovarian Cancer Syndrome May 24, 2018
Genetics & Genomics Which Genetic Test Performed on Tumor Cells Has Prognostic and Predictive Uses? May 24, 2018
Patient Financial Advocacy Financial Toxicity Discussion Needs to Include Undocumented Patients May 22, 2018
U.S. Food and Drug Administration (FDA) FDA Reports Efficacy Issue for Patients Taking Pembrolizumab or Atezolizumab as Monotherapy to Treat Urothelial Cancer with Low Expression of PD-L1 May 18, 2018
U.S. Food and Drug Administration (FDA) FDA Approves Epoetin Alfa-Epbx as a Biosimilar to Epoetin Alfa May 16, 2018
Treatment Side Effects Manage Diarrhea in Patients Receiving Nerlynx® (Neratinib) Tablets May 11, 2018
ONS Board of Directors Board Continues to Align ONS to Meet Changing Member and Healthcare Needs May 10, 2018
Chemotherapy What’s the Preferred Method for Vincristine Administration When Treating a Patient With Lymphoma or Leukemia? May 10, 2018
Nursing Education New Eligibility Criteria for Initial Oncology Certification Begin in 2019 May 09, 2018
Cancer Risk Prevention Childhood Obesity May Be a Factor in Increasing Cancer Rates in Young Adults May 09, 2018
Treatment Side Effects Evidence for Nephrotoxicity Prevention With Cisplatin Therapy Is Still Limited May 08, 2018
U.S. Food and Drug Administration (FDA) FDA Approves Tisagenlecleucel for Adults with Relapsed or Refractory Large B-Cell Lymphoma May 03, 2018
Clinical Practice Guidelines Which Is Not an ONS Recommendation When Accessing an Implanted Port? May 03, 2018
Oncology Nurse Influence How Does Mentorship Help New Oncology Nurse Authors Get Published? May 01, 2018
Nursing Professional Development Oncology Nurses Enhance Cancer Care Through Mentorship Opportunities May 01, 2018
U.S. Food and Drug Administration (FDA) FDA Approves Dabrafenib Plus Trametinib for Adjuvant Treatment of Melanoma With BRAF V600E or V600K Mutations April 30, 2018
Biotherapy Biosimilars Offer New Options for Treatment and New Concepts for Patient Education April 24, 2018
Evidence-Based Practice Use These Methods to Evaluate EBP Outcomes and Disseminate Results April 19, 2018
U.S. Food and Drug Administration (FDA) FDA Approves Nivolumab Plus Ipilimumab Combination for Renal Cell Carcinoma April 16, 2018
U.S. Food and Drug Administration (FDA) FDA Approves Everolimus for TSC-Associated Partial-Onset Seizures April 11, 2018